UK: Behind The Co-Investment Curtain: Current "Market" Terms Revealed

Last Updated: 13 August 2019
Article by Mark Silveira

Co-investments are now an integral part of the private equity funds market, popular with GPs and LPs alike. In a classic co-investment, an investor is invited by a GP to make a separate, additional investment in a target company (the Target) alongside the main investment being made by the GP's fund (the Sponsor Fund). Co-investors may acquire the Target's shares directly, or their exposure to the Target may be indirect, through a co-investment vehicle (the CIV) run by the Sponsor Fund's GP. The CIV may be dedicated to just the one deal, or it may be a standing vehicle making multiple co-investments.

Although CIVs resemble mini-funds (indeed, they are often structured as limited partnerships, with the Sponsor Fund GP serving as general partner), they are heavily customised for the co-investors and investment(s) in question, and differ from conventional blind pool funds in several aspects:

Management fees

GPs use co-investment opportunities as a way to cement and grow the relationship with key LPs in their existing funds. That's one reason why management fees on co-investments are kept comparatively low – typically 0.5% to 1% of committed capital, invested capital or net invested capital, per year, as against the 1.5% to 2% seen in conventional blind pool funds. Some CIVs are fee-free, or only charge fees to co-investors who are not LPs in the Sponsor Fund.

Target fees

Even in a zero-fee vehicle, the GP may be able to take (without an accompanying offset obligation) one-off transaction and annual monitoring fees from the Target directly, which together comprise a de facto management fee. Co-investors (particularly if they are LPs in the Sponsor Fund, which can be expected to have its own complete or partial fee offset) typically negotiate to prohibit Target-level fees or, if they are commercially justified, to fix or cap them.


Like fees, CIV carried interest is invariably lower than in blind pool funds. We usually see co-investment carry in the 5% to 15% range. Ratcheted carry is increasingly popular: the carry rate moves up or down in line with total cash returns to co-investors. If the GP earns substantial fees from the CIV, then there may be zero carry. If co-investors pay carry, then they will benefit from a hurdle – generally, 6% to 8%.


Transaction-related expenses (with the possible exception of abort costs; see below) are apportioned between the Sponsor Fund and the co-investors in line with their investments in the Target, whereas the CIV's own setup and operating expenses are generally met entirely by the co-investors. Expenses may be drawn down from co-investors' capital commitments, as in a mainstream fund, or they may be structured as an add-on liability (i.e., on top of commitments). Expenses are often capped – indeed, this is essential if they are an add-on liability, which would otherwise be open-ended. Placement agent fees are rare in the context of co-investments. If at all incurred, it is established market practice that they are borne by the manager alone, not the co-investors.

Abort costs

Deal-specific CIVs typically admit co-investors near the end of the transaction, when there is a low probability that the deal will collapse. If it does collapse, the CIV is unlikely to have ever seen the light of day. In that case, abort costs (essentially, the costs of due diligence by legal counsel and other advisers incurred before a proposed transaction collapses) would in all likelihood be wholly met by the Sponsor Fund, not the prospective co-investors.

This practice, although common historically, was not always clearly disclosed to LPs either before or after they joined the Sponsor Fund. A number of high-profile regulatory enforcement actions and settlements in America during and since the Obama years brought greater investor and public attention to the issue. In the current generation of funds, virtually all GPs disclose their allocation policy for abort costs in the LPA and/or PPM.

This comes in three main flavours:

  • The most common, even among new-vintage funds, is to give the GP clear discretion to allocate abort costs, including the ability to book them all in the Sponsor Fund.
  • The main alternative (which is steadily gaining ground and is now the second most common policy in new-vintage funds), broadly speaking, requires the GP to apportion abort costs between the Sponsor Fund and prospective co-investors on a pro rata basis. To make this work in practice, the GP needs to get contractual undertakings from prospective co-investors that they will pay their fair share of abort costs.
  • Very occasionally, one will see an outright cap on the Sponsor Fund's aggregate liability for abort costs.

GP commitment

GP commitments are exceedingly rare in a classic co-investment vehicle, if only because the management team is investing concurrently in the Target via the existing GP commitment in the Sponsor Fund, and thereby has 'skin in the game', believed to align the team's interests with those of its investors.

Further co-investors and follow-ons

Single-deal CIVs generally do not admit new co-investors in the future except with the consent of existing co-investors or where the latter have passed on the opportunity to increase their commitments in the CIV in order to fund follow-on investments. Existing co-investors will effectively be diluted (at the Target level) if they don't participate in follow-ons on a pro rata basis with their original co-investment.

Minority investor protection

An investor whose sole exposure to the Target comes through its limited partner interest in the Sponsor Fund does not actively 'choose' the Target, but a co-investor does. Moreover, if a big chunk of the acquisition is financed by co-investment, then the co-investing LPs are really more like minority shareholders in a joint venture. This raises an additional set of considerations which impact on the terms of the CIV's LPA.

As an overriding principle, they should want the CIV to be treated pari passu with the Sponsor Fund – investing in and divesting from the Target at the same time and on the same terms. This can be reinforced by tag and drag rights in the Target shareholders' agreement.

Co-investing LPs may also push for 'pass through' reserved matters on Target finances and activity. These may include things like adding or refinancing debt, diluting the CIV's stake in the Target by issuing new shares, material amendments to the shareholders' agreement, etc. The GP (which ultimately controls the Target by virtue of its control of the combined shareholdings of the Sponsor Fund and CIV) agrees not to undertake any reserved matter without co-investors' consent.

Co-investors may also seek regular performance reports and copies of Target board packs. A dominant LP co-investor may have sufficient sway to have one of its representatives attend meetings of the Target's board as an observer.

We explore many of these issues in more depth in the MJ Hudson Private Equity Co-Investments Manual.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions